Moors & Cabot, Inc. Vaccinex, Inc. Transaction History

Moors & Cabot, Inc.

  • $1.85 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023
BUY
$0.44 - $131.17 $4,400 - $1.31 Million
10,000 New
10,000 $6,000
Q3 2021

Nov 05, 2021
BUY
$2.11 - $2.81 $21,100 - $28,100
10,000 New
10,000 $11,000

Others Institutions Holding VCNX

# of Institutions
2
Shares Held
426K
Call Options Held
0
Put Options Held
0
View Full List

About VACCINEX, INC.

VCNX Quotes by TradingView
  • Ticker VCNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,664,100
  • Market Cap $240M
  • Description
  • Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab,...
More about VCNX
Track This Portfolio

Track Moors & Cabot, Inc. Portfolio

Follow Moors & Cabot, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Moors & Cabot, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email